Accuracy of detection of colorectal neoplasia using an immunochemical occult blood test in symptomatic referred patients: Comparison of retrospective and prospective studies

Internal Medicine

Volumn 39, Issue 9, 2000, Pages 701-706

  Miyoshi, Hirofumi ^a   Oka, Masaki ^b   Sugi, Kazunori ^b   Saitoh, Osamu ^b   Katsu, Ken Ichi ^b   Uchida, Kazuo ^b  

^a University of Kobe   (Japan)

^b NONE

Author keywords

Hemoglobin; Transferrin

Indexed keywords

HEMOGLOBIN; TRANSFERRIN;

ADENOMA; AGED; ANALYTICAL EQUIPMENT; ARTICLE; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; IMMUNOCHEMISTRY; MALE; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRANSFERRIN;

EID: 0034266601     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.701     Document Type: Article

References (37)

1. Mandel JS, Bond JH, Church TR, et al, for the Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328: 1365-1371, 1993.
2. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy? JAMA 271: 1011-1013, 1994.
3. Ahlquist DA, Wieand HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA 269: 1262-1267, 1993.
4. Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA. Fecal blood levels in health and disease: a study using HemoQuant. N Engl J Med 312: 1422-1428, 1985.
5. Bang KM, Tillett S, Hoar SK, Blair A, McDougall V. Sensitivity of fecal Hemoccult testing and flexible sigmoidscopy for colorectal cancer screening. J Occup Med 28: 709-713, 1986.
6. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer: a controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 62: 645-651, 1988.
7. Ahlquist DA, McGill DB, Fleming JL, el al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 63: 1826-1830, 1989.
8. Jahn H, Joergensen OD, Kronborg O, Fenger C. Can Hemoccult II replace colonoscopy in surveillance after radical surgery for colorectal cancer or after polypectomy? Dis Colon Rectum 35: 253-256, 1992.
9. Iwase T. Evaluation of an immunochemical fecal occult blood test by reversal passive hemagglutination compared with Hemoccult II screening for colorectal cancer. in: Young GP, Saito H, eds. Fecal Occult Blood Tests: Current Issues and New Tests, Smith Kline Diagnostics Inc, San Jose, Calif, 1992: 90-95.
10. St John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104: 1661-1668, 1993.
11. Adams EC, Layman Km. Immunochemical confirmation of gastrointestinal bleeding. Ann Clin Lab Sci 4: 343-349, 1974.
12. Barrows GH, Burton RM, Jarrett DD, Russell GG, Alford MD, Songster CL. Immunochemical detection of human blood in feces. Am J Clin Path 69: 342-346, 1987.
13. Burton RM, Landreth KS, Barrows GH, Jarrett DD, Songster CL. Appearance, properties, and origin of altered human hemoglobin in feces. Lab Invest 35: 111-115, 1976.
14. Jensen J. Biosynthesis of hematin compounds in hemin-requiring strain of Micrococcus pyogenes var. aureus. J Bacteriol 73: 324-333, 1957.
15. Francis RT Jr, Booth JW, Becker RR. Uptake of iron from hemoglobin and haptoglobin-hemoglobin complex by hemolytic bacteria. Int J Biochem 17: 767-773, 1985.
16. Uchida K, Matsuse R, Toyoda E, Miyachi N, Okuda S, Tomita S. Study on immunochemical fecal occult blood tests. Jpn Clin Lab Int Reag 11: 167-172, 1988 (in Japanese).
17. Uchida K, Matsuse R, Miyachi N, et al. A new immunochemical fecal occult blood test: combination assay of hemoglobin and transferrin. Jpn J Clin Pathol 37: 58-62, 1989 (in Japanese).
18. Uchida K, Matsuse R, Miyachi N, et al. Immunochemical detection of human blood in feces. Clin Chim Acta 189: 267-274, 1990.
19. Miyoshi H, Uchida K, Matsuse R, et al. Clinical study of a new fecal occult blood test using a combination assay of hemoglobin and transferrin. Gastroenterol Jpn 26: 151-156, 1991.
20. Miyoshi H, Ohshiba S, Asada S, Hirata I, Uchida K. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests. Am J Gastroenterol 87: 67-73, 1992.
21. Kira A. Design criteria for defecation. in: The Bathroom. The Viking Press, Inc., New York, 1976: 118-141.
22. Saito H, Tsuchida S, Kakizaki K, et al. An immunological fecal occult blood test for mass screening of colorectal cancer by reversed passive haemagglutination (RPHA). Jpn J Gastroenterol 81: 2831, 1984 (in Japanese).
23. Takeshita T, Horiguchi J, Kinoshita T, et al. Immunological fecal occult blood testing (latex-agglutination method) for screening for colorectal cancer. J Jpn Soc Coloproctology 38: 780-783, 1985 (in Japanese).
24. Morson BC. Precancerous and early malignant lesions of the large intestine. Br J Surg 55: 725-731, 1968.
25. Muto T, Bussey HJR, Morson BC. The evolution of cancer of colon and rectum. Cancer 36: 2251-2270, 1975.
26. Miyoshi H, Uchida K, Shimamoto C, et al. The usefulness of measurement of fecal transferrin in patients with colorectal neoplasia. Stomach and Intestine 24: 827-829, 1989 (in Japanese).
27. Lance P. Fecal occult blood tests: What's new? Gastroenterology 104: 1852-1855, 1993.
28. Curless R, French J, Williams GV, James OFW. Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age. Gut 35: 1267-1270, 1994.
29. Lynn RB, Friedman LS. Irritable bowel syndrome. N Engl J Med 329: 1940-1945, 1993.
30. Colin-Jones DG. Management of dyspepsia: report of working party. Lancet i: 576-579, 1988.
31. Survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin 35: 197-213, 1985.
32. National Cancer Institute. Working Guidelines for Early Detection: Rationale and Supporting Evidence to Decrease Mortality. Bethesda, MD: National Cancer Institute, Division of Cancer Prevention and Control, Early Detection Branch, 1987.
33. Czaja R, McFall SL, Warnecke RB, Ford L, Kaluzny AD. Preferences of community physicians for cancer screening guidelines. Ann Intern Med 120: 602-608, 1994.
34. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326: 658-662, 1992.
35. Atkin WS, Cuzick J, Northover JMA, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341: 736-740, 1993.
36. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653-657, 1992.
37. Austoker J. Screening for colorectal cancer. BMJ 309: 382-386, 1994.